Literature DB >> 8739840

Changes in mediobasal hypothalamic dopamine and indoleamine metabolism after superior cervical ganglionectomy of rats.

A I Esquifino1, A Arce, R M Muñoz, M A Villanúa, D P Cardinali.   

Abstract

Eight days after bilateral superior cervical ganglionectomy (Gx) of rats, norepinephrine content of medial basal hypothalamus (MBH) decreased significantly by 44-50%. To obtain information on other possible neurochemical sequela of Gx in MBH, we examined the metabolism of dopamine and serotonin in MBH of Gx rats by employing a high pressure liquid chromatography procedure. Eight days after Gx, MBH dopamine levels augmented significantly. Assessment of dopamine metabolism by measuring dihydroxyphenylacetic acid (DOPAC)/dopamine and homovanillic acid (HVA)/dopamine indexes indicated a significant decrease of MBH DOPAC/dopamine ratio after Gx. MBH serotonin levels increased, and 5-hydroxyindoleacetic acid (5-HIAA)/serotonin index decreased significantly in Gx rats. To examine the interaction Gx-induced changes on MBH dopamine and serotonin with the modified hormonal milieu produced by an ectopic pituitary transplant, adult male rats bearing an ectopic pituitary within the pectoral muscles from day 5 of life were submitted to Gx on day 60 of life and were studied 8 days later. MBH dopamine content increased significantly after pituitary grafting, an effect counteracted by a subsequent Gx, while Gx alone augmented MBH dopamine levels. DOPAC and HVA contents augmented in pituitary-grafted animals, an effect counteracted by Gx. Gx increased MBH serotonin content in control but not in pituitary-grafted rats. After pituitary grafting a decrease in MBH 5-HIAA levels was found, an effect reversed by Gx. Pituitary transplants brought about a significant increase of MBH DOPAC/dopamine index, and a significant decrease in 5-HIAA/serotonin index, both effects being counteracted by Gx. Gx of control rats resulted in a significant decrease of MBH 5-HIAA/serotonin index. Analyzed as a main effect in a factorial analysis of variance, Gx decreased MBH DOPAC/dopamine and HVA/dopamine indexes significantly. Plasma prolactin increased in pituitary-grafted rats, an effect further increased by a subsequent Gx. In pituitary-grafted, Gx rats plasma GH levels augmented significantly. The data suggest that superior cervical ganglion removal affects differentially dopamine and indoleamine metabolism in MBH of control and pituitary-grafted rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739840     DOI: 10.1007/BF01271240

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  23 in total

1.  Hypothalamic luteinizing hormone-releasing hormone content and serum luteinizing hormone levels in male rats during wallerian degeneration of sympathetic nerve terminals after superior cervical ganglionectomy.

Authors:  H E Romeo; P Arias; B Szwarcfarb; J A Moguilevsky; D P Cardinali
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Studies and reevaluations of some aspects on thyroid function after superior cervical sympathetic gangliectomy in rats.

Authors:  P Langer; B Mess; C Ruzsás; K Gschwendtová; O Földes; M Bukovská
Journal:  Endocrinol Exp       Date:  1989-09

3.  The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain.

Authors:  A Björklund; R Y Moore; A Nobin; U Stenevi
Journal:  Brain Res       Date:  1973-03-15       Impact factor: 3.252

4.  Lack of effect of noradrenergic denervation of the hypothalamus and medial preoptic area on the feedback regulation of gonadotropin secretion and the estrous cycle of the rat.

Authors:  G Nicholson; G Greeley; J Humm; W Youngblood; J S Kizer
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

5.  Photoperiodic control of thyroid function and wool and horn growth in rams and the effect of cranial sympathectomy.

Authors:  G A Lincoln; H Klandorf; N Anderson
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

6.  Restraint-induced changes in serum luteinizing hormone, prolactin, growth hormone and corticosterone levels in rats: effect of superior cervical ganglionectomy.

Authors:  A I Martín; A López-Calderón; J A Tresguerres; M I González-Quijano; D P Cardinali
Journal:  Neuroendocrinology       Date:  1995-02       Impact factor: 4.914

7.  Involvement of the cervical sympathetic nervous system in the changes of calcium homeostasis during turpentine oil-induced stress in rats.

Authors:  J E Stern; M G Ladizesky; M I Keller Sarmiento; D P Cardinali
Journal:  Neuroendocrinology       Date:  1993-03       Impact factor: 4.914

8.  Rat prolactin and hypothalamic catecholamine nerve terminal systems. Evidence for rapid and discrete increases in dopamine and noradrenaline turnover in the hypophysectomized male rat.

Authors:  K Andersson; K Fuxe; P Eneroth; F Nyberg; P Roos
Journal:  Eur J Pharmacol       Date:  1981-12-03       Impact factor: 4.432

9.  Changes in drinking behavior caused by superior cervical ganglionectomy and pinealectomy in rats.

Authors:  P V Gejman; D P Cardinali; S Finkielman; V E Nahmod
Journal:  J Auton Nerv Syst       Date:  1981-09

10.  Changes in parathyroid hormone and calcium levels after superior cervical ganglionectomy of rats.

Authors:  D P Cardinali; M G Ladizesky
Journal:  Neuroendocrinology       Date:  1985-04       Impact factor: 4.914

View more
  2 in total

1.  Superior cervical ganglionectomy differentially modifies median eminence and anterior and mediobasal hypothalamic GABA content in male rats: effects of hyperprolactinemia.

Authors:  A I Esquifino; M P Alvarez; P Cano; V Jiménez; B Duvilanski
Journal:  Exp Brain Res       Date:  2004-02-19       Impact factor: 1.972

2.  The Role of the Superior Cervical Sympathetic Ganglion in Ischemia Reperfusion-Induced Acute Kidney Injury in Rats.

Authors:  Wencui Zhang; Zhen Li; Zhixiao Li; Tianning Sun; Zhigang He; Anne Manyande; Weiguo Xu; Hongbing Xiang
Journal:  Front Med (Lausanne)       Date:  2022-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.